A Year of Purpose and Progress: Dr. Christina Rahm Celebrates Global Growth, Scientific Breakthroughs, and International Honors 
Smart for Life to Participate in MicroCap Rodeo’s ‘Lassoing the Big Apple’ Conference May 16-17
Conference Represents Initiation of Enhanced Outreach Activities to Increase AwarenessMIAMI, April 24, 2023 (GLOBE NEWSWIRE) -- Smart for Life, Inc....
Panbela to Host First Quarter 2023 Earnings Conference Call on May 4, 2023
MINNEAPOLIS, April 24, 2023 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for the...
Pharma Two B to Present Additional Positive Results from P2B001 Phase 3 Trial at 2023 American Academy of Neurology Annual Meeting
Results showed P2B001, a once-daily fixed-dose combination of low dose pramipexole and low dose rasagiline, showed comparable efficacy to marketed...
Qualigen Therapeutics, Inc. Receives Nasdaq Notice Regarding Delayed Form 10-K Filing
CARLSBAD, Calif., April 21, 2023 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (“Qualigen” or “the Company,” Nasdaq: QLGN), a diversified life...
Vaxcyte Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
SAN CARLOS, Calif., April 21, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity...
AB Science announces the implementation of a new strategy and the launch of a capital increase
PRESS RELEASE FOCUS OF THE DEVELOPMENT STRATEGY ON AMYOTROPHIC LATERAL SCLEROSIS WITH THE MASITINIB PLATFORM AND ON THE SECOND MICROTUBULE...
Tenaya Therapeutics to Participate at Chardan’s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
SOUTH SAN FRANCISCO, Calif., April 21, 2023 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with...
Pennant Announces First Quarter 2023 Earnings Release and Call
EAGLE, Idaho, April 21, 2023 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of operating subsidiaries...
Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
PHILADELPHIA, April 21, 2023 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (Nasdaq: PASG), a clinical-stage genetic medicines company focused on developing...
Xenon Pharmaceuticals to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference
BURNABY, British Columbia, April 21, 2023 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that...
Entourage Health Reschedules Full-Year 2022 Earnings Conference Call to Align with First Quarter 2023 Results
Company Financials for Full-Year 2022 to be filed by May 1, 2023.TORONTO, April 21, 2023 (GLOBE NEWSWIRE) -- Entourage Health...
Arvinas to Present at Stifel Targeted Oncology Day
NEW HAVEN, Conn., April 21, 2023 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new...
Smart for Life Announces Reverse Stock Split
Stock Split is a Key Element of Company’s Strategic Initiatives as It Prepares for Next Generation of Its Acquisition FinancingsMIAMI,...
Vallon Pharmaceuticals Completes Merger with GRI Bio, Inc.
Combined company will operate as GRI Bio, Inc. and advance innovative pipeline of Natural Killer T (“NKT”) modulating therapies for...
Ultimovacs ASA – Share Option Program
Oslo, 21 April 2023: On the basis of the approval by the General Meeting on 20 April 2023 to authorize...
Doheny Eye Institute Announces Upcoming Presentations at ARVO 2023 Annual Meeting
More than 30 Doheny Scientists and Clinician-Scientists Selected to Give Talks and Present Papers and Posters; Also Hosting a Breakfast...
Lexicon To Present Results From LX9211 Phase 2 Trial In Postherpetic Neuralgia At The 2023 American Academy Of Neurology (AAN) Annual Meeting And The British Pain Society (BPS) 56th Annual Scientific Meeting 2023
Data accepted as AAN Late-Breaking AbstractTHE WOODLANDS Texas, April 21, 2023 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today...
Disc Medicine to Participate in H.C. Wainwright BioConnect Investor Conference
WATERTOWN, Mass., April 21, 2023 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery,...
Clearmind Medicine Expanding IP Portfolio with New US Patent Application for Treatment of Depression
The application is for a novel psychedelic-based combination, of Clearmind's MEAI and SciSparc's Cannamide™ Tel Aviv, Israel / Vancouver, Canada,...
SciSparc and Clearmind Collaboration Strengthens IP Portfolio with Patent Application in the U.S. for Treatment of Depression
The application refers to a novel psychedelic-based combination of Clearmind's MEAI and SciSparc's Cannamide™ TEL AVIV, Israel, April 21, 2023 (GLOBE NEWSWIRE)...